Official data from USPTO

FKB

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Activate monitoring for this trademark Talk to an expert

Quick snapshot

FKB

ST13

US500000079313063

Class

5, 10, 35, 40, 42, 44

Filing

79313063

Registration

6810852

View on USPTO

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

Latest update

11/05/2023

Trademark type

Word

Nice classes

5, 10, 35, 40, 42, 44

Filing date

05/10/2021

Registration date

08/09/2022

Expiration date

Complete case details

Structured fields from the responsible authority and the official record.

Status date

08/09/2022

Last transaction

11/05/2023

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

Owner type

Owner location

Examiner

KAPLAN, VALERIE

Law office

L70

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

FUJIFILM KYOWA KIRIN BIOLOGICS Co., Ltd.

Representatives

Kaushal Odedra ODEDRA LAW OFFICE, PLLC

Technical classification

Nice Classes

Class 5Class 10Class 35Class 40Class 42Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations for use in connection with humans for the treatment of infectious diseases; pharmaceutical preparations for use in connection with humans for the prevention of infectious diseases; pharmaceutical preparations for use in connection with humans for the treatment of parasitic diseases; pharmaceutical preparations for use in connection with humans for the prevention of parasitic diseases; pharmaceutical preparations for use in connection with humans for the treatment of neoplasms; pharmaceutical preparations for use in connection with humans for the prevention of neoplasms; pharmaceutical preparations for use in connection with humans for the treatment of diseases of the blood; pharmaceutical preparations for use in connection with humans for the prevention of diseases of the blood; pharmaceutical preparations for use in connection with humans for the treatment of diseases of blood-forming organs; pharmaceutical preparations for use in connection with humans for the prevention of diseases of blood-forming organs; pharmaceutical preparations for use in connection with humans for the treatment of diseases of certain disorders involving the immune mechanism; pharmaceutical preparations for use in connection with humans for the prevention of diseases of certain disorders involving the immune mechanism; pharmaceutical preparations for use in connection with humans for the treatment of endocrine diseases; pharmaceutical preparations for use in connection with humans for the prevention of endocrine diseases; pharmaceutical preparations for use in connection with humans for the treatment of nutritional diseases; pharmaceutical preparations for use in connection with humans for the prevention of nutritional diseases; pharmaceutical preparations for use in connection with humans for the treatment of metabolic diseases; pharmaceutical preparations for use in connection with humans for the prevention of metabolic diseases; pharmaceutical preparations for use in connection with humans for the treatment of mental disorders; pharmaceutical preparations for use in connection with humans for the prevention of mental disorders; pharmaceutical preparations for use in connection with humans for the treatment of behavioural disorders; pharmaceutical preparations for use in connection with humans for the prevention of behavioural disorders; pharmaceutical preparations for use in connection with humans for the treatment of diseases of the nervous system; pharmaceutical preparations for use in connection with humans for the prevention of diseases of the nervous system; pharmaceutical preparations for use in connection with humans for the treatment of diseases of the eye; pharmaceutical preparations for use in connection with humans for the prevention of diseases of the eye; pharmaceutical preparations for use in connection with humans for the treatment of diseases of eye adnexa; pharmaceutical preparations for use in connection with humans for the prevention of diseases of eye adnexa; pharmaceutical preparations for use in connection with humans for the treatment of diseases of the ear; pharmaceutical preparations for use in connection with humans for the prevention of diseases of the ear; pharmaceutical preparations for use in connection with humans for the treatment of diseases of the mastoid process; pharmaceutical preparations for use in connection with humans for the prevention of diseases of the mastoid process; pharmaceutical preparations for use in connection with humans for the treatment of diseases of the circulatory system; pharmaceutical preparations for use in connection with humans for the prevention of diseases of the circulatory system; pharmaceutical preparations for use in connection with humans for the treatment of diseases of the respiratory system; pharmaceutical preparations for use in connection with humans for the prevention of diseases of the respiratory system; pharmaceutical preparations for use in connection with humans for the treatment of diseases of the digestive system; pharmaceutical preparations for use in connection with humans for the prevention of diseases of the digestive system; pharmaceutical preparations for use in connection with humans for the treatment of diseases of the skin; pharmaceutical preparations for use in connection with humans for the prevention of diseases of the skin; pharmaceutical preparations for use in connection with humans for the treatment of diseases of subcutaneous tissue; pharmaceutical preparations for use in connection with humans for the prevention of diseases of subcutaneous tissue; pharmaceutical preparations for use in connection with humans for the treatment of diseases of the musculoskeletal system pharmaceutical preparations for use in connection with humans for the prevention of diseases of the musculoskeletal system; pharmaceutical preparations for use in connection with humans for the treatment of diseases of the connective tissue; pharmaceutical preparations for use in connection with humans for the prevention of diseases of the connective tissue; pharmaceutical preparations for use in connection with humans for the treatment of diseases of the genitourinary system; pharmaceutical preparations for use in connection with humans for the prevention of diseases of the genitourinary system; pharmaceutical preparations for use in connection with humans for the treatment of infectious diseases and diabetes occurred in pregnancy; pharmaceutical preparations for use in connection with humans for the prevention of infectious diseases and diabetes occurred in pregnancy; pharmaceutical preparations for use in connection with humans for the treatment of infectious diseases occurred in childbirth; pharmaceutical preparations for use in connection with humans for the prevention of infectious diseases occurred in childbirth; pharmaceutical preparations for use in connection with humans for the treatment of infectious diseases occurred in the puerperium; pharmaceutical preparations for use in connection with humans for the prevention of infectious diseases occurred in the puerperium; pharmaceutical preparations for use in connection with humans for the treatment of nutritional deficiency conditions originating in the perinatal period; pharmaceutical preparations for use in connection with humans for the prevention of nutritional deficiency conditions originating in the perinatal period; pharmaceutical preparations for use in connection with humans for the treatment of congenital malformations; pharmaceutical preparations for use in connection with humans for the prevention of congenital malformations; pharmaceutical preparations for use in connection with humans for the treatment of deformations; pharmaceutical preparations for use in connection with humans for the prevention of deformations; pharmaceutical preparations for use in connection with humans for the treatment of chromosomal abnormalities; pharmaceutical preparations for use in connection with humans for the prevention of chromosomal abnormalities; prescribed pharmaceutical preparations for the treatment of infectious diseases; prescribed pharmaceutical preparations for the prevention of infectious diseases; prescribed pharmaceutical preparations for the treatment of parasitic diseases; prescribed pharmaceutical preparations for the prevention of parasitic diseases; prescribed pharmaceutical preparations for the treatment of neoplasms; prescribed pharmaceutical preparations for the prevention of neoplasms; prescribed pharmaceutical preparations for the treatment of diseases of the blood; prescribed pharmaceutical preparations for the prevention of diseases of the blood prescribed pharmaceutical preparations for the treatment of diseases of blood-forming organs; prescribed pharmaceutical preparations for the prevention of diseases of blood-forming organs; prescribed pharmaceutical preparations for the treatment of diseases of certain disorders involving the immune mechanism; prescribed pharmaceutical preparations for the prevention of diseases of certain disorders involving the immune mechanism; prescribed pharmaceutical preparations for the treatment of endocrine diseases; prescribed pharmaceutical preparations for the prevention of endocrine diseases; prescribed pharmaceutical preparations for the treatment of nutritional diseases; prescribed pharmaceutical preparations for the prevention of nutritional diseases; prescribed pharmaceutical preparations for the treatment of metabolic diseases; prescribed pharmaceutical preparations for the prevention of metabolic diseases; prescribed pharmaceutical preparations for the treatment of mental disorders; prescribed pharmaceutical preparations for the prevention of mental disorders; prescribed pharmaceutical preparations for the treatment of behavioural disorders; prescribed pharmaceutical preparations for the prevention of behavioural disorders; prescribed pharmaceutical preparations for the treatment of diseases of the nervous system; prescribed pharmaceutical preparations for the prevention of diseases of the nervous system; prescribed pharmaceutical preparations for the treatment of diseases of the eye; prescribed pharmaceutical preparations for the prevention of diseases of the eye; prescribed pharmaceutical preparations for the treatment of diseases of eye adnexa; prescribed pharmaceutical preparations for the prevention of diseases of eye adnexa; prescribed pharmaceutical preparations for the treatment of diseases of the ear; prescribed pharmaceutical preparations for the prevention of diseases of the ear; prescribed pharmaceutical preparations for the treatment of diseases of the mastoid process; prescribed pharmaceutical preparations for the prevention of diseases of the mastoid process; prescribed pharmaceutical preparations for the treatment of diseases of the circulatory system; prescribed pharmaceutical preparations for the prevention of diseases of the circulatory system; prescribed pharmaceutical preparations for the treatment of diseases of the respiratory system; prescribed pharmaceutical preparations for the prevention of diseases of the respiratory system; prescribed pharmaceutical preparations for the treatment of diseases of the digestive system; prescribed pharmaceutical preparations for the prevention of diseases of the digestive system; prescribed pharmaceutical preparations for the treatment of diseases of the skin; prescribed pharmaceutical preparations for the prevention of diseases of the skin; prescribed pharmaceutical preparations for the treatment of diseases of subcutaneous tissue; prescribed pharmaceutical preparations for the prevention of diseases of subcutaneous tissue; prescribed pharmaceutical preparations for the treatment of diseases of the musculoskeletal system; prescribed pharmaceutical preparations for the prevention of diseases of the musculoskeletal system; prescribed pharmaceutical preparations for the treatment of diseases of the connective tissue; prescribed pharmaceutical preparations for the prevention of diseases of the connective tissue; prescribed pharmaceutical preparations for the treatment of diseases of the genitourinary system; prescribed pharmaceutical preparations for the prevention of diseases of the genitourinary system; prescribed pharmaceutical preparations for the treatment of infectious diseases and diabetes occurred in pregnancy; prescribed pharmaceutical preparations for the prevention of infectious diseases and diabetes occurred in pregnancy; prescribed pharmaceutical preparations for the treatment of infectious diseases occurred in childbirth; prescribed pharmaceutical preparations for the prevention of infectious diseases occurred in childbirth; prescribed pharmaceutical preparations for the treatment of infectious diseases occurred in the puerperium; prescribed pharmaceutical preparations for the prevention of infectious diseases occurred in the puerperium; prescribed pharmaceutical preparations for the treatment of nutritional deficiency conditions originating in the perinatal period; prescribed pharmaceutical preparations for the prevention of nutritional deficiency conditions originating in the perinatal period; prescribed pharmaceutical preparations for the treatment of congenital malformations; prescribed pharmaceutical preparations for the prevention of congenital malformations; prescribed pharmaceutical preparations for the treatment of deformations; prescribed pharmaceutical preparations for the prevention of deformations; prescribed pharmaceutical preparations for the treatment of chromosomal abnormalities; prescribed pharmaceutical preparations for the prevention of chromosomal abnormalities; biological pharmaceutical preparations for the treatment of infectious diseases; biological pharmaceutical preparations for the prevention of infectious diseases; biological pharmaceutical preparations for the treatment of parasitic diseases; biological pharmaceutical preparations for the prevention of parasitic diseases; biological pharmaceutical preparations for the treatment of neoplasms; biological pharmaceutical preparations for the prevention of neoplasms; biological pharmaceutical preparations for the treatment of diseases of the blood; biological pharmaceutical preparations for the prevention of diseases of the blood; biological pharmaceutical preparations for the treatment of diseases of blood-forming organs; biological pharmaceutical preparations for the prevention of diseases of blood-forming organs; biological pharmaceutical preparations for the treatment of diseases of certain disorders involving the immune mechanism; biological pharmaceutical preparations for the prevention of diseases of certain disorders involving the immune mechanism; biological pharmaceutical preparations for the treatment of endocrine diseases; biological pharmaceutical preparations for the prevention of endocrine diseases; biological pharmaceutical preparations for the treatment of nutritional diseases; biological pharmaceutical preparations for the prevention of nutritional diseases; biological pharmaceutical preparations for the treatment of metabolic diseases; biological pharmaceutical preparations for the prevention of metabolic diseases; biological pharmaceutical preparations for the treatment of mental disorders; biological pharmaceutical preparations for the prevention of mental disorders; biological pharmaceutical preparations for the treatment of behavioural disorders; biological pharmaceutical preparations for the prevention of behavioural disorders; biological pharmaceutical preparations for the treatment of diseases of the nervous system; biological pharmaceutical preparations for the prevention of diseases of the nervous system; biological pharmaceutical preparations for the treatment of diseases of the eye; biological pharmaceutical preparations for the prevention of diseases of the eye; biological pharmaceutical preparations for the treatment of diseases of eye adnexa; biological pharmaceutical preparations for the prevention of diseases of eye adnexa; biological pharmaceutical preparations for the treatment of diseases of the ear; biological pharmaceutical preparations for the prevention of diseases of the ear; biological pharmaceutical preparations for the treatment of diseases of the mastoid process; biological pharmaceutical preparations for the prevention of diseases of the mastoid process; biological pharmaceutical preparations for the treatment of diseases of the circulatory system; biological pharmaceutical preparations for the prevention of diseases of the circulatory system; biological pharmaceutical preparations for the treatment of diseases of the respiratory system; biological pharmaceutical preparations for the prevention of diseases of the respiratory system; biological pharmaceutical preparations for the treatment of diseases of the digestive system; biological pharmaceutical preparations for the prevention of diseases of the digestive system; biological pharmaceutical preparations for the treatment of diseases of the skin; biological pharmaceutical preparations for the prevention of diseases of the skin; biological pharmaceutical preparations for the treatment of diseases of subcutaneous tissue; biological pharmaceutical preparations for the prevention of diseases of subcutaneous tissue; biological pharmaceutical preparations for the treatment of diseases of the musculoskeletal system; biological pharmaceutical preparations for the prevention of diseases of the musculoskeletal system; biological pharmaceutical preparations for the treatment of diseases of the connective tissue; biological pharmaceutical preparations for the prevention of diseases of the connective tissue; biological pharmaceutical preparations for the treatment of diseases of the genitourinary system; biological pharmaceutical preparations for the prevention of diseases of the genitourinary system; biological pharmaceutical preparations for the treatment of infectious diseases and diabetes occurred in pregnancy; biological pharmaceutical preparations for the prevention of infectious diseases and diabetes occurred in pregnancy; biological pharmaceutical preparations for the treatment of infectious diseases occurred in childbirth; biological pharmaceutical preparations for the prevention of infectious diseases occurred in childbirth; biological pharmaceutical preparations for the treatment of infectious diseases occurred in the puerperium; biological pharmaceutical preparations for the prevention of infectious diseases occurred in the puerperium; biological pharmaceutical preparations for the treatment of nutritional deficiency conditions originating in the perinatal period; biological pharmaceutical preparations for the prevention of nutritional deficiency conditions originating in the perinatal period; biological pharmaceutical preparations for the treatment of congenital malformations; biological pharmaceutical preparations for the prevention of congenital malformations; biological pharmaceutical preparations for the treatment of deformations; biological pharmaceutical preparations for the prevention of deformations; biological pharmaceutical preparations for the treatment of chromosomal abnormalities; biological pharmaceutical preparations for the prevention of chromosomal abnormalities; bandages for dressings

Class 10

Apparatus for drug administrationdrug delivery systemscomprised of injectorautoinjectorboth sold empty; therapeutic inhalerssold empty; high frequency electromagnetic therapy apparatus; oxygen inhalers for therapeutic purposes sold empty; ultraviolet radiator units for therapeutic purposes; defibrillators; pneumothorax apparatusmedical apparatus for diagnosing or treating respiratory conditions; heart pacemakers; mercury arc lamp units for therapeutic purposes; infrared radiator units for therapeutic purposes; puncture apparatus for therapeutic purposesmedical devices for closing wounds; lavage apparatus for therapeutic purposesapparatus for washing out body cavities; carbon arc lamp units for therapeutic purposes; injection syringessyringe barrels; injection needles; infusion apparatus for therapeutic purposesinfusion pumps for delivering measured amounts of solutions into the bloodstream over rime; ultrasonic therapy machines and apparatus; short wave therapy machines and apparatus; therapeutic bath apparatus and instrumentsappliances for washing body cavities; massage apparatus for medical purposes; low frequency electric therapy apparatus; static electric therapy apparatus; dialyzersblood component separation apparatus for medical purposes; acupuncture needles; sprayers for medical purposesdrug delivery sprayers sold empty; suture apparatus for medical purposessuture needles and suture materials; radioisotope therapy apparatus and instruments; incubators for babies; blood transfusion apparatus; containers and trays specially designed for transporting and holding pharmaceuticals; injection device for pharmaceuticals; injection instruments without needles; injection instruments with needles

Class 35

Providing information concerning commercial sales in the field of pharmaceuticals

Class 40

Custom manufacture of pharmaceuticals

Class 42

Pharmaceutical research; pharmaceutical development

Class 44

Pharmaceutical information services provided via the Internetproviding information relating to diagnosticprophylactic and therapeutic properties of pharmaceuticals; medical information services provided via the Internet; providing medical information

Publications

History of USPTO decisions and trademark events.

27 publications found

RNWL

INTERNATIONAL REGISTRATION RENEWED

10/06/2023

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

01/15/2023

XXSS

GENERIC MADRID TRANSACTION SENT TO IB

11/18/2022

XXCR

GENERIC MADRID TRANSACTION CREATED

11/18/2022

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

11/09/2022

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

08/09/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

08/09/2022

GPNX

NOTIFICATION PROCESSED BY IB

05/30/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

05/24/2022

PUBO

PUBLISHED FOR OPPOSITION

05/24/2022

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

05/04/2022

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

05/04/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

05/04/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

04/18/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

04/18/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/18/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

04/18/2022

RFNT

REFUSAL PROCESSED BY IB

03/21/2022

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

02/23/2022

RFRR

REFUSAL PROCESSED BY MPU

02/23/2022

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

01/29/2022

CNRT

NON-FINAL ACTION WRITTEN

01/28/2022

DOCK

ASSIGNED TO EXAMINER

01/14/2022

MAFR

APPLICATION FILING RECEIPT MAILED

06/29/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

06/25/2021

LIMI

LIMITATION FROM ORIGINAL APPLICATION ENTERED

06/21/2021

SDRC

SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

06/11/2021

Continuous trademark protection

Get notified about every new filing that threatens FKB or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.

Activate watch Consult specialist